Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): A randomized, double-blinded, placebo-controlled parallel multi-center trial Academic Article uri icon

Overview

MeSH Major

  • Neuroprotective Agents
  • Riluzole
  • Spinal Cord Injuries

abstract

  • This study will provide class I evidence regarding the safety and neuroprotective efficacy of riluzole in patients with acute cervical SCI.

publication date

  • January 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5399137

Digital Object Identifier (DOI)

  • 10.1038/sc.2015.95

PubMed ID

  • 26099215

Additional Document Info

start page

  • 8

end page

  • 15

volume

  • 54

number

  • 1